Literature DB >> 11395044

Impaired fibrinolysis and increased fibrinogen levels in South Asian subjects.

K Kain1, A J Catto, P J Grant.   

Abstract

The potential role of haemostatic risk markers is largely unexplored in South Asians, who have increased morbidity and mortality from cardiovascular disease and an increased prevalence of insulin resistance. To investigate differences in thrombotic risk markers between South Asian and White populations, 42 Asian and 50 White males and 96 Asian and 80 White females, clinically free from vascular disease, were recruited. Venous blood samples were taken for measures of haemostasis and determination of blood lipids. South Asian females showed lower fasting blood glucose than White females (4.6 vs. 4.8 mmol/l, P<0.008). In the South Asian population, total cholesterol was lower in females, with a similar trend in males (females 5.0 vs. 5.5 mmol/l, P<0.001; males 5.1 vs. WM 5.5 mmol/l, P=0.09), but no difference in triglyceride levels. South Asian subjects of both genders had markedly higher levels of fibrinogen (females 3.3 vs. 2.8 mg/dl, P<0.0005; males 3.0 vs. 2.5 mg/dl P<0.002) and PAI-1 activity (females 14.6 vs. 8.7 ng/ml, P<0.0005, males 21.3 vs. 12.2 ng/ml, ) P<0.0005). Factor VII:C was lower in both South Asian groups (females 110.9 vs. 122.4%, P<0.005; males 103.3 vs. 125%, P<0.0005). Factor XII was lower in South Asian females and there were no differences in Factor XII levels in male populations. These results suggest that elevated PAI-1 and fibrinogen in Asians of both genders may contribute to the increased vascular risk experienced in this population; however, the role of dyslipidaemia and Factor VII are not clear in these processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395044     DOI: 10.1016/s0021-9150(00)00684-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Ethnic differences in cardiovascular disease.

Authors:  Nish Chaturvedi
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

2.  Prevalence of metabolic syndrome and associated risk factors in Asian Indians.

Authors:  Ajay Balasubramanyam; Shaun Rao; Ranjita Misra; Rajagopal V Sekhar; Christie M Ballantyne
Journal:  J Immigr Minor Health       Date:  2008-08

Review 3.  Type 2 diabetes and cardiovascular risk in the UK south Asian community.

Authors:  A H Barnett; A N Dixon; S Bellary; M W Hanif; J P O'hare; N T Raymond; S Kumar
Journal:  Diabetologia       Date:  2006-07-18       Impact factor: 10.122

4.  Childhood body mass index and adult pro-inflammatory and pro-thrombotic risk factors: data from the New Delhi birth cohort.

Authors:  Ramakrishnan Lakshmy; Caroline Hd Fall; Harshpal Singh Sachdev; Clive Osmond; Dorairaj Prabhakaran; Sushant Dey Biswas; Nikhil Tandon; Siddharth Ramji; Kolli Srinath Reddy; David Jp Barker; Santosh K Bhargava
Journal:  Int J Epidemiol       Date:  2010-07-26       Impact factor: 7.196

5.  Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease.

Authors:  Michelle A Albert; Robert J Glynn; Julie E Buring; Paul M Ridker
Journal:  Am J Cardiol       Date:  2007-03-15       Impact factor: 2.778

Review 6.  Cerebrovascular disease in South Asia - Part II: Risk factors and prevention.

Authors:  Deepti Vibha; Kameshwar Prasad
Journal:  JRSM Cardiovasc Dis       Date:  2012-11-30

7.  The Relationship of Metabolic Syndrome Traits with Beta-Cell Function and Insulin Sensitivity by Oral Minimal Model Assessment in South Asian and European Families Residing in the Netherlands.

Authors:  Thekla Geragotou; Sjaam Jainandunsing; Behiye Özcan; Felix W M de Rooij; Alexander Kokkinos; Nicholas Tentolouris; Eric J G Sijbrands
Journal:  J Diabetes Res       Date:  2016-08-11       Impact factor: 4.011

8.  Tranexamic acid reduces postoperative blood loss in Chinese pediatric patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Zhi-Yao Zou; Li-Xian He; Yun-Tai Yao
Journal:  Medicine (Baltimore)       Date:  2022-03-04       Impact factor: 1.817

9.  Low dose aprotinin increases mortality and morbidity in coronary artery bypass surgery(*).

Authors:  Feridoun Sabzi; Gholam Reza Moradi; Heidar Dadkhah; Alireza Poormotaabed; Samsam Dabiri
Journal:  J Res Med Sci       Date:  2012-01       Impact factor: 1.852

Review 10.  Is hyperlipidemia a potential protective factor against intraoperative awareness in cardiac surgery?

Authors:  Qingshui Zheng; Qian Wang; Chaoqun Wu; Zhifa Wang; Hushan Ao
Journal:  J Cardiothorac Surg       Date:  2016-04-12       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.